2508 Three-arm phase II randomized trial of docetaxel monotherapy or combined with ramucirumab or icrucumab in second-line locally advanced or metastatic urothelial carcinoma Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Petrylak, DP
  • Tagawa, ST
  • Kohli, M
  • Eisen, Andrea
  • Canil, C
  • Sridhar, SS
  • Spira, A
  • Yu, EY
  • Burke, JM
  • Shaffer, D
  • Pan, CX
  • Kim, JJ
  • Aragon-Ching, JB
  • Tang, S
  • Zhang, H
  • Cavanaugh, CT
  • Kauh, JS
  • Walgren, RA
  • Chi, KN

publication date

  • September 2015